Sarah Premji, MD
@SPremji7866
Followers
294
Following
962
Media
21
Statuses
131
Assistant Director Breast Cancer at Sarah Cannon Research Institute
Nashville, TN
Joined August 2019
In the blink of an eye - fellowship is over! Grateful to @MayoCancerCare for 3 transformative years of excellent training and mentorship! Beyond excited to join a group I deeply admire at @SCRIOncology who has already warmly welcomed me! @mpgoetz @jonaspaludo @ErikaHamilton9
4
3
80
RT @OncBrothers: Role of CDK 4/6i (Abema or Ribo) in Stage III breast cancer at @ASCO Daily news by @matteolambe and @Lucarecco . #OncTwitt….
0
35
0
RT @JaniceTNBCmets: This is so important for people dx w/ #metastaticbreastcancer! . Hopefully in the (very) near future, SOC guidelines wi….
0
7
0
I’ll be reviewing this and having a debate with the brilliant @BCJoyceO September in Miami @GreatDebatesCME.
Act on ctDNA before you see progression? Some say yes, it’s the next frontier in personalizing breast cancer care. Others say the data is not there yet. Where do you land?. Should We Be Using ctDNA to Direct Changes in Therapy in the Absence of Progression in Breast Cancer?.
0
0
4
Miami in September 🔥 #greatdebates.@GreatDebatesCME.
See why oncology professionals are heading to Miami this Sept 🎥👇. #GDST #GreatDebates #Cancer #Oncology #MedicalEducation. @BiachiTiago @ChaftJamie @CathyEngMD @NarjustFlorezMD @gandhi_shipra @ErikaHamilton9 @HardingJJMD @DavidHongMD @YJanjigianMD @CoreyLangerMD @michael_lidsky
0
0
4
RT @OncBrothers: Are you going to be at #SABCS25? Let’s🗣️ the current SoC & how #SABCS25 will impact this!. InPerson: Dec 10, 2025 w/ @DrSG….
0
25
0
RT @LoiSher: ⛳️important new data for #bcsm 👏👏👏 on #pregnancy & #breastfeeding feeding after breast cancer @JCO_ASCO .Congrats to all invo….
0
7
0
RT @GreatDebatesCME: We’re fortunate to have several exceptional faculty from @SylvesterCancer joining us at Great Debates in Solid Tumors….
0
5
0
RT @ALLIANCE_org: New Trial! @adawaksmd of @DanaFarber leads @ALLIANCE_org A012303 (ShortStop-HER2), a study exploring if less treatment is….
0
10
0
RT @VJOncology: 🎥@ErikaHamilton9 (@SarahCannonDocs) highlights vepdegestrant’s potential as a new endocrine backbone in metastatic breast c….
vjoncology.com
Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, comments on the potential of vepdegestrant as a novel endocrine backbone in the treatment of metastatic breast cancer, particularly...
0
3
0
RT @stage4kelly: It warms my 🫀(and frankly brings a tear to my 👁️) to see Anne Loeser’s legacy live on (and grow!!): first citation in this….
ascopubs.org
0
5
0
RT @SarahCannonDocs: New from @CancerNetwork: @ErikaHamilton9 of @SCRIOncology shares insights on ADCs, CDK4/6 inhibitors & early breast….
cancernetwork.com
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
0
3
0
RT @PTarantinoMD: Multiple ADCs have outperformed chemo for treating mBC. Yet their most transformative impact is expected in the curative….
0
48
0
RT @BreastCancersTd: ADCs take the spotlight at #ASCO25:.🏆 T-DXd + P tops THP in HER2+ MBC.💥 SG + pembro shows 1L promise in PD-L1+ TNBC.🧬….
0
1
0
RT @celcuity: Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival Primary Endpoints from PIK3CA Wild-Typ….
0
3
0
RT @ErikaHamilton9: Proud to share my interview in @AMJ_Oncology reflecting on #ASCO25, the future of ADCs, and how we’re turning knowledge….
emjreviews.com
As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture in...
0
8
0
RT @ASCO: Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful….
0
22
0
Check out our review of neoadjuvant therapies in triple negative breast cancer and what we believe could be the future, published in @AMJ_Reviews with @rleonferre! .
emjreviews.com
Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, characterized by the...
0
2
12
RT @ASCO: ICYMI: Dr. Robert A. Figlin, @OncNewsCentral's Peer-Spectives podcast host, spoke to our CEO @CliffordHudis about challenges acad….
0
7
0
RT @AlexisLevee: Excited to share our review of side effects of novel and emerging #breastcancer therapies in the @ASCO Educational Book. V….
0
6
0
RT @GFarrugiaMD: Dr. Roxana Dronca, a medical oncologist, colleague, and longtime friend, has created a lasting legacy for her daughter May….
mayomagazine.mayoclinic.org
Maya Dronca dreamt of being a doctor like her mom, Roxana Dronca, M.D. Cancer denied her that opportunity, but she created a lasting legacy at Mayo Clinic all the same.
0
14
0